Bipolar Sealer for Reduction of Blood Loss in Anterior Total Hip Arthroplasties

Exclusion Criteria

• •Active local or systemic infection.
• •Hematologic disease either inherited or acquired, that would predispose the patient to anemia or increased intra-operative blood loss
• •Currently taking anti-coagulation medications more than 81 mg aspirin every day.
• •Platelet disorder either inherited or acquired with a serum platelet level \<150,000 platelets per microliter.
• •Coagulopathy as seen with routine lab work
• •Unstable/uncontrolled cardiovascular disease such as congestive heart failure, hypertension, or renal disease such as GFR \<70, in the opinion of the investigative team and PI.
• •Excessive alcohol intake or tobacco use, in the opinion of the investigator.
• •Uncontrolled diabetes mellitus with hemoglobin a1c \>7.5%.
• •Established history of previous venous thrombotic events (VTE).
• •Loss of musculature, neuromuscular compromise or vascular deficiency in the affected limb rendering the procedure unjustified.
• •The subject is a woman who is pregnant or lactating.
• •Subject had a contralateral amputation.
• •Previous partial hip replacement in affected hip.
• •Subject has participated in a clinical investigation with an investigational product (drug or device) in the last three months.
• •Contralateral hip was replaced less than 3 months prior to surgery date, contralateral hip is already enrolled in the study, or simultaneous or staged hip replacement is planned
• •Subject is currently involved in any personal injury litigation, medical-legal or worker's compensation claims.
• •Subject was diagnosed and is taking prescription medications to treat a muscular disorder that limits mobility due to severe stiffness and pain such as fibromyalgia or polymyalgia.
• •Subject, in the opinion of the Investigator, is a drug or alcohol abuser or has a physical or psychological disorder that could affect their ability to complete patient reported questionnaires or be compliant with follow-up requirements.